Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3018688	ampicillin	u/ml (—)	69	71	100.00%	Distribution not available
3018688	s-ampise	u/ml (—)	57	58	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other and unspecified urticaria

35.55

73.14

1.0

1.1

—

Urticaria and erythema

19.05

72.68

1.0

—

Urticaria

21.27

70.84

1.0

—

Adverse effects, not elsewhere classified

17.20

43.64

1.1

1.0

—

Allergic rhinitis

14.66

41.08

1.0

—

Dermatitis and eczema

8.11

40.30

1.0

—

Other and unspecified effects of external causes

13.74

39.89

1.1

1.0

—

Pollen allergy

16.04

39.48

1.0

—

Vasomotor and allergic rhinitis

11.02

34.53

1.0

—

Diseases of the skin and subcutaneous tissue

12.55

29.96

1.0

—

Dermatitis due to substances taken internally

41.88

23.62

1.1

1.0

—

Other special examinations and investigations of persons without complaint or reported diagnosis

+∞

21.92

1.0

0.0

—

Follow-up examination after treatment for conditions other than malignant neoplasms

+∞

21.17

1.0

0.0

—

Complications of medical and surgical care

5.55

21.09

1.1

1.0

—

Generalized skin eruption due to drugs and medicaments

42.27

20.48

1.1

1.0

—

Medical observation and evaluation for suspected diseases and conditions

+∞

20.45

1.0

0.0

—

Acute generalized exanthematous pustulosis

36.20

19.85

1.1

1.0

—

Allergic contact dermatitis

21.75

18.14

1.0

—

Examination and observation for other reasons

+∞

17.46

1.0

0.0

—

Atopic dermatitis

5.96

16.95

1.0

—

General examination and investigation of persons without complaint and reported diagnosis

+∞

15.08

1.0

0.0

—

Other soft tissue disorders, not elsewhere classified

4.50

14.89

1.0

—

ILD medications

3.92

13.43

1.0

—

Persons encountering health services for examination and investigation

+∞

13.25

1.0

0.0

—

Asthma (only as main-diagnosis), excluding more controls

6.16

13.00

1.0

—

Special screening examination for infectious and parasitic diseases

+∞

12.92

1.0

0.0

—

ILD medications: prednisolone, methylprednisolone, prednisone

3.87

12.84

1.0

—

Certain infectious and parasitic diseases

4.45

12.81

1.0

—

Asthma (only as main-diagnosis)

6.00

12.80

1.0

—

Asthma, unspecified (mode), excluding more controls

6.86

12.70

1.0

—

Asthma, unspecified (mode)

6.63

12.38

1.0

—

Erysipelas

5.82

12.28

1.0

—

Diseases of oesophagus, stomach and duodenum

3.66

11.98

1.0

—

Asthma

5.63

11.95

1.0

—

Other diseases of upper respiratory tract

4.15

11.77

1.0

1.1

—

Asthma, excluding more controls

5.62

11.49

1.0

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

5.67

11.32

1.0

1.1

—

Abnormalities of breathing

3.81

10.82

1.0

1.1

—

Asthma (mode)

5.36

10.76

1.0

—

Complications of surgical and medical care, not elsewhere classified

3.47

10.65

1.1

1.0

—

Acute upper respiratory infections

3.46

10.50

1.0

—

Pain in limb

3.89

9.90

1.0

—

Oral corticosteroids

3.28

9.85

1.0

—

Tramadol

3.93

9.73

1.1

1.0

—

Dermatitis

4.98

9.50

1.0

—

Inflammatory bowel disease treatment related agents

3.12

9.20

1.0

—

Pain in joint

4.89

9.10

1.0

—

Intestinal infectious diseases

3.25

9.04

1.0

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.98

9.03

1.0

—

First line medication for Crohn's disease

3.18

8.70

1.0

—

Oedema, not elsewhere classified

8.46

8.69

1.0

—

Other intervertebral disc disorders

3.66

8.56

1.1

1.0

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

16.30

8.54

1.2

1.0

—

3.12

8.52

1.0

—

Acute upper respiratory infections of multiple and unspecified sites

3.53

8.46

1.0

—

Dyspnoea

3.30

8.41

1.0

—

Diarrhoea and gastroenteritis of presumed infectious origin

3.63

8.39

1.0

—

Other disorders of urethra and urinary system

3.61

8.37

1.1

1.0

—

Other and unspecified drugs and medicaments

14.49

8.19

1.2

1.0

—

Gastro-oesophageal reflux disease

3.68

8.14

1.0

—

Osteopathies and chondropathies

3.90

7.96

1.0

—

Other bacterial diseases

3.21

7.89

1.1

1.0

—

4.01

7.68

1.0

—

Persons encountering health services in other circumstances, wide

2.94

7.62

1.0

—

Unspecified privation

10.03

7.52

1.2

1.0

—

Complications of procedures, not elsewhere classified

3.18

7.52

1.0

—

Headache

3.52

7.50

1.0

—

Lumbar disc prolapse

3.76

7.48

1.0

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2.95

7.42

1.0

—

Asthma (diagnoses ohter than nonallergic)

2.98

7.42

1.0

—

Excluding asthma or asthma-COPD overlap

4.27

7.14

1.0

—

Other pulmonary diagnosis

4.27

7.14

1.0

—

COPD differential diagnosis

4.27

7.14

1.0

—

ILD differential diagnosis

4.27

7.14

1.0

—

GASTRO-related operations

3.60

7.10

1.0

—

Any gastric operation

3.60

7.10

1.0

—

Bronchitis

2.78

7.07

1.0

—

COPD/asthma/ILD related infections

3.00

7.05

1.0

—

COPD/asthma related infections

3.00

7.05

1.0

—

Erysipelas

3.59

7.04

1.1

1.0

—

Implicit Sepsis

3.38

6.97

1.1

1.0

—

Chronic diseases of tonsils and adenoids

3.50

6.91

1.0

1.1

—

Functional dyspepsia

7.51

6.88

1.1

1.0

—

Asthma-related infections

3.47

6.87

1.0

—

Asthma, hospital admission 2, infections

3.47

6.87

1.0

—

Other specific joint derangements/joint disorders

3.36

6.83

1.0

—

Sciatica+with lumbago

3.97

6.75

1.1

1.0

—

Cystitis

3.02

6.72

1.0

—

Oxycodone

6.15

6.69

1.1

1.0

—

Diseases of the respiratory system

4.76

6.62

1.1

—

Chronic rhinitis, nasopharyngitis and pharyngitis

6.40

6.62

1.0

—

Pain in throat and chest

3.17

6.58

1.0

1.1

—

Myalgia

6.16

6.45

1.0

—

Other and unspecified dermatitis

5.30

6.44

1.0

—

Chronic sinusitis

5.48

6.27

1.0

—

Injury, poisoning and certain other consequences of external causes

5.35

6.22

1.0

—

Abnormalities of heart beat

5.38

6.17

1.0

—

Low back pain

3.11

6.09

1.1

1.0

—

Other bacterial diseases

2.72

5.95

1.1

1.0

—

Disorders of lacrimal system

3.67

5.88

1.0

—

Implicit viral Sepsis

6.37

5.84

1.0

—

Type of accident

5.34

5.83

1.1

1.0

—

General symptoms and signs

2.80

5.83

1.0

—

Migraine

3.03

5.80

1.0

—

Migraine with aura

3.91

5.70

1.1

1.0

—

Lower back pain or/and sciatica

2.54

5.62

1.1

1.0

—

Excessive, frequent and irregular menstruation

4.11

5.60

1.0

—

Other nutritional deficiencies

2.76

5.56

1.0

—

Other condition

8.47

5.55

1.1

1.0

—

Certain infectious and parasitic diseases

3.56

5.53

1.0

—

Other diseases of urinary system

2.68

5.46

1.0

—

Obesity due to excess calories

3.14

5.45

1.0

—

Intestinal infectious diseases

2.51

5.44

1.0

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

4.85

5.41

1.1

1.0

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.01

5.34

1.0

—

Chronic laryngitis and laryngotracheitis

11.26

5.28

1.0

1.1

—

Other dorsopathies, not elsewhere classified

2.70

5.25

1.0

—

Concussion

3.37

5.24

1.1

1.0

—

External causes of morbidity and mortality

3.81

5.22

1.0

—

Other disorders of lacrimal gland

3.64

5.19

1.0

—

Syncope and collapse

4.72

5.17

1.1

1.0

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

7.34

5.13

1.0

1.1

—

Dorsalgia

2.68

5.05

1.0

—

Persons encountering health services in other circumstances

3.73

5.04

1.1

1.0

—

Asthma, hospital admissions , main diagnosis only

2.57

5.00

1.0

—

Other arthrosis

3.82

4.98

1.1

1.0

—

Ethmoidectomy

7.70

4.84

1.0

—

Fall on same level

2.37

4.82

1.1

1.0

—

Implicit Sepsis

2.73

4.77

1.1

1.0

—

Bacterial Sepsis

4.58

4.76

1.1

1.0

—

Systemic connective tissue disorders

3.57

4.76

1.1

1.0

—

Nerve, nerve root and plexus disorders

2.41

4.72

1.1

1.0

—

Other disorders of veins

3.25

4.69

1.1

1.0

—

Autoimmune diseases related-to ILD

2.49

4.69

1.1

1.0

—

Parasetamol

3.22

4.68

1.0

—

Factors influencing health status and contact with health services

+∞

4.68

1.0

0.0

—

Diseases of the ear and mastoid process

2.32

4.65

1.1

1.0

—

Obesity

2.59

4.64

1.0

—

Obesity and other hyperalimentation

2.59

4.63

1.0

—

Other complications of surgical and medical care, not elsewhere classified

8.20

4.56

1.1

—

Other abnormal uterine and vaginal bleeding

5.73

4.48

1.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

2.48

4.47

1.1

1.0

—

Soft tissue disorders

2.57

4.37

1.0

—

Other septicaemia

5.57

4.29

1.1

1.0

—

Fever of other and unknown origin

3.24

4.28

1.2

1.0

—

Allergic urticaria

11.69

4.27

1.0

—

Gastric ulcer

11.67

4.27

1.0

—

Cardiovascular diseases

2.81

4.25

1.0

—

Nausea and vomiting

5.39

4.20

1.0

—

Intracranial injury

2.94

4.18

1.1

1.0

—

FESS (DNB20)

6.93

4.16

1.0

—

Implicit bacterial Sepsis

4.49

4.15

1.2

1.0

—

Other external causes of accidental injury

2.73

4.14

1.0

—

Infections of the skin and subcutaneous tissue

2.81

4.13

1.1

1.0

—

Depression or dysthymia

2.90

4.12

1.0

1.1

—

Dysphagia

5.89

4.12

1.1

1.0

—

Polyarthrosis

6.97

4.12

1.0

1.1

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

4.68

4.11

1.0

—

Conjunctivitis

2.37

4.09

1.0

—

Asthma/COPD (KELA code 203)

2.34

4.07

1.0

—

Ulcer of lower limb, not elsewhere classified

8.01

4.06

1.0

1.1

—

ILD medications: immunosuppressive drugs

2.88

4.04

1.2

1.0

—

Other diseases of intestines

2.27

4.03

1.0

—

Convalescence

10.03

4.01

1.0

—

Abdominal and pelvic pain

2.56

4.01

1.0

—

Other systemic involvement of connective tissue (FG)

4.56

4.00

1.2

1.0

—

Fracture of lumbar spine and pelvis

5.00

3.99

1.0

—

Obesity related asthma

3.89

3.98

1.1

1.0

—

Implicit bacterial Sepsis

4.62

3.98

1.2

1.0

—

Disorders of eyelid, lacrimal system and orbit

2.41

3.98

1.0

—

Atopic dermatitis, strict definition with reimbursement

4.19

3.97

1.0

—

Dentofacial anomalies [including malocclusion]

2.37

3.91

1.1

1.0

—

Condition for Implicit Sepsis (Organ dysfunction codes)

2.45

3.90

1.1

1.0

—

Symptoms and signs involving the circulatory and respiratory systems

2.42

3.87

1.0

1.1

—

Rheumatism, unspecified

6.01

3.81

1.1

1.0

—

Chronic gastritis

6.00

3.81

1.0

—

Oxicams

7.31

3.80

1.0

—

Malaise and fatigue

3.31

3.79

1.1

1.0

—

Codeine

2.40

3.79

1.0

—

Diseases of external ear

3.94

3.78

1.2

1.0

—

Conjunctivitis (acute, non atopic)

3.67

3.77

1.0

—

Undetermined asthma

12.00

3.76

1.0

—

Undetermined asthma, excluding more controls

12.00

3.76

1.0

—

Septicaemia

4.68

3.76

1.1

1.0

—

Dorsopathies

2.37

3.75

1.0

—

Cholelithiasis, broad definition with cholecystitis

2.36

3.74

1.0

—

Vocal cord dysfunction

8.98

3.73

1.0

—

Other noninfective gastroenteritis and colitis

4.58

3.73

1.0

—

Diarrhoea and gastroenteritis of presumed infectious origin

2.25

3.72

1.0

—

Neurological diseases, wide definition

6.28

3.72

1.0

—

Disorders of gallbladder, biliary tract and pancreas

2.26

3.71

1.1

1.0

—

Symptoms and signs involving the urinary system

2.58

3.71

1.1

1.0

—

Accidents

2.62

3.71

1.0

—

Pain, not elsewhere classified

4.14

3.69

1.1

1.0

—

Recurrent or chronic depression

3.04

3.67

1.0

—

Disorders of conjunctiva

2.26

3.66

1.0

—

Implicit viral Sepsis

5.63

3.65

1.0

—

Viral Sepsis

5.63

3.65

1.0

—

Genitourinary diseases

3.42

3.64

1.0

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

4.40

3.61

1.0

—

Temporomandibular joint disorders, including avohilmo

2.60

3.61

1.1

1.0

—

Striking against or struck by other objects

3.71

3.58

1.2

1.0

—

Autoimmune diseases excluding thyroid diseases, strict definition

2.29

3.57

1.1

1.0

—

Other diseases of lip and oral mucosa

2.94

3.56

1.0

—

Persons encountering health services for specific procedures and health care

2.13

3.56

1.1

1.0

—

Gastroduodenal ulcer

7.76

3.55

1.0

—

Symptoms and signs involving the skin and subcutaneous tissue

2.39

3.53

1.0

—

Cholelithiasis

2.33

3.52

1.0

—

Chondropathies

5.30

3.50

1.0

—

Migraine with aura and triptan purchases

4.24

3.50

1.1

1.0

—

Fibromyalgia

6.16

3.50

1.1

1.0

—

Other symptoms and signs involving the digestive system and abdomen

6.16

3.50

1.3

1.0

—

Falls/tendency to fall

2.19

3.49

1.0

—

Gastrointestinal diseases

2.91

3.47

1.0

—

Intracranial trauma

2.69

3.39

1.1

1.0

—

Acute pancreatitis

5.72

3.34

1.1

—

Antihypertensive medication - note that there are other indications

2.44

3.33

1.0

—

Menorrhagia

3.80

3.32

1.0

—

Chronic lower respiratory diseases

2.07

3.32

1.0

—

Other disorders of bone

4.35

3.30

1.0

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

3.06

3.30

1.0

—

Pain and other conditions associated with female genital organs and menstrual cycle

4.38

3.28

1.1

1.0

—

Mycoses

2.20

3.26

1.0

—

Chronic ulcer of skin, not elsewhere classified

8.58

3.26

1.0

—

Noninflammatory disorders of female genital tract

3.14

3.25

1.0

—

Noninfective enteritis and colitis

2.77

3.24

1.0

—

Other systemic involvement of connective tissue

3.53

3.19

1.2

1.0

—

Cervicobrachial syndrome

4.17

3.19

1.0

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

6.37

3.18

1.1

1.0

—

Diseases of the eye and adnexa

2.40

3.18

1.0

—

Other/unspecified dorsalgia

3.50

3.16

1.2

1.0

—

Inflammatory diseases of female pelvic organs

2.19

3.13

1.0

—

Finngen Rheumatological endpoints

2.21

3.12

1.0

—

Acute sinusitis

2.65

3.12

1.1

1.0

—

Diseases of the musculoskeletal system and connective tissue

3.19

3.11

1.0

—

Coxarthrosis [arthrosis of hip](FG)

3.39

3.11

1.2

1.0

—

Other disorders of patella

4.50

3.11

1.0

1.1

—

Diaphragmatic hernia

3.43

3.10

1.0

—

Cardiovascular diseases (excluding rheumatic etc)

2.32

3.09

1.0

—

Polyarthropathies

2.64

3.05

1.1

1.0

—

Autoimmune diseases excluding thyroid diseases

2.12

3.04

1.1

1.0

—

Diseases of salivary glands

2.89

3.02

1.0

—

Candidiasis

3.34

3.01

1.1

1.0

—

Renal tubulo-interstitial diseases

2.18

3.00

1.1

1.0

—

Allergic asthma (mode)

4.90

2.99

1.0

—

Allergic asthma (mode), excluding more controls

4.89

2.99

1.0

—

Cervicalgia

4.29

2.99

1.0

—

Cellulitis

4.29

2.99

1.1

1.0

—

Soft tissue disorders related to use, overuse and pressure

4.29

2.99

1.0

—

Spondylopathies

2.56

2.98

1.1

1.0

—

Renal failure

3.60

2.98

1.2

1.0

—

Ovarian cyst

3.13

2.95

1.0

—

Non-ischemic cardiomyopathy

4.95

2.92

1.1

1.0

—

DVT of lower extremities

4.71

2.91

1.3

1.1

—

Acute bronchitis

2.83

2.91

1.0

—

Asthma, including avohilmo

1.98

2.86

1.0

—

Disorders of synovium and tendon

2.73

2.86

1.1

1.0

—

Symptoms and signs involving the digestive system and abdomen

2.26

2.83

1.0

—

Other arrhythmias

2.35

2.83

1.0

—

Coxarthrosis

3.30

2.81

1.2

1.0

—

Acute pancreatitis (for exclusion)

4.45

2.79

1.1

—

Internal derangement of knee

3.32

2.79

1.0

—

Deviated nasal septum

4.44

2.79

1.1

—

Effects of foreign body entering through natural orifice

3.91

2.77

1.0

—

Other anxiety disorders

2.42

2.76

1.0

—

Neurotic, stress-related and somatoform disorders

2.01

2.75

1.0

—

Heart failure, not strict

2.40

2.73

1.1

1.0

—

Pain associated with micturition

5.01

2.72

1.0

1.1

—

Pain (limb, back, neck, head abdominally)

2.67

2.72

1.1

1.0

—

All kidney diseases

2.01

2.72

1.1

1.0

—

Anxiety disorders

2.00

2.72

1.0

—

Glucagon-like peptide-1 (GLP-1) analogues

3.24

2.72

1.0

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

3.24

2.72

1.0

—

Nutritional anaemias

2.72

1.1

1.0

—

Condition for Implicit Sepsis (Organ dysfunction codes)

2.09

2.71

1.1

1.0

—

Acute pharyngitis

4.96

2.70

1.0

—

Inflammatory disorders of breast

6.01

2.70

1.0

—

Unspecified/other endometriosis

6.01

2.70

1.0

—

Other gastritis (incl. Duodenitis)

6.00

2.69

1.0

—

Cholecystectomy

2.21

2.69

1.1

1.0

—

Other joint disorders

2.23

2.69

1.0

—

Other disorders of skin and subcutaneous tissue

2.25

2.68

1.0

—

Inflammatory disease of uterus

4.21

2.67

1.0

1.1

—

Biological medication for rheuma

4.21

2.67

1.1

1.0

—

Other heart diseases, wide

2.04

2.67

1.0

—

Female infertility

3.04

2.66

1.0

—

Spondylosis

2.88

2.65

1.1

—

Other acute lower respiratory infections

2.46

2.60

1.0

—

Trochanteric bursitis

4.67

2.59

1.0

—

All-cause Heart Failure

3.24

2.59

1.1

1.0

—

Heart failure,strict

3.23

2.59

1.1

1.0

—

Oral lichen planus, including avohilmo , including avohilmo

7.15

2.55

1.0

—

Achilles tendinitis

7.15

2.55

1.0

—

Spontaneous rupture of synovium and tendon

7.15

2.55

1.2

1.0

—

Polycystic ovarian syndrome, consortium definition

1.97

2.55

1.0

—

Unspecified urinary incontinence

5.46

2.54

1.0

1.1

—

Papulosquamous disorders

2.73

2.54

1.2

1.0

—

Asthma and allergy

7.05

2.52

1.0

—

Hypothyroidism (congenital or acquired)

3.53

2.51

1.0

1.1

—

Spinal stenosis

3.09

2.50

1.1

—

Iron deficiency anaemia

2.82

2.49

1.1

1.0

—

Heart failure, strict

3.10

2.48

1.1

1.0

—

Cough

2.97

2.46

1.0

—

Codeine or tramadol medication

1.89

2.46

1.0

—

Other disorders of ear

2.01

2.45

1.1

1.0

—

Injuries to the head

1.88

2.41

1.1

1.0

—

Opioids

2.04

2.40

1.0

—

Deforming dorsopathies

3.33

2.39

1.1

1.0

—

Basal cell carcinoma, including avohilmo

2.76

2.38

1.0

—

Female infertility, associated with anovulation

6.26

2.37

1.0

—

Atopic dermatitis, strict definition

2.61

2.35

1.0

—

Infections with a predominantly sexual mode of transmission

2.61

2.35

1.0

—

Other viral diseases, not elsewhere classified

3.01

2.33

1.0

—

Cardiac arrhythmias

2.17

2.32

1.1

1.0

—

Explicit Sepsis

3.01

2.32

1.1

1.0

—

Constipation

1.99

2.31

1.1

1.0

—

Visual disturbances and blindness

2.31

2.30

1.1

1.0

—

Cutaneous abscess, furuncle and carbuncle

3.22

2.30

1.0

—

Cervical disc disorders

3.22

2.30

1.0

1.1

—

Anxiety disorders, excluding more controls

1.99

2.30

1.0

—

Other and unspecified iron deficiency

2.94

2.27

1.0

—

Dislocation, sprain and strain of joints and ligaments of knee

2.13

2.27

1.1

1.0

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

1.91

2.26

1.0

—

Dizziness and giddiness

2.06

2.26

1.1

1.0

—

Autoimmune diseases

1.91

2.26

1.1

1.0

—

Tumor necrosis factor alpha inhibitors

3.89

2.25

1.1

1.0

—

Somatoform disorder

3.89

2.25

1.1

—

All influenza

3.89

2.25

1.0

—

Other disorders of fluid, electrolyte and acid-base balance

3.46

2.24

1.1

1.0

—

Shoulder lesions

2.39

2.23

1.0

—

Basal cell carcinoma

2.82

2.23

1.0

—

Childhood asthma (age<16)

4.73

2.22

1.0

—

Childhood asthma (age<16), excluding more controls

4.73

2.22

1.0

—

Viral infections characterized by skin and mucous membrane lesions

102

1.93

2.22

1.0

—

Other shoulder lesions

5.56

2.21

1.0

—

Impacted cerumen

5.56

2.21

1.2

1.1

—

Psoriatic arthropathies

5.56

2.21

1.2

1.1

—

Visual disturbances

2.33

2.21

1.1

1.0

—

Codes for special purposes

2.33

2.20

1.1

1.0

—

Provisional assignment of new diseases of uncertain etiology

2.33

2.20

1.1

1.0

—

Fall on same level involving ice and snow

2.19

2.20

1.1

1.0

—

Varicose veins

2.31

2.20

1.1

1.0

—

Viral and other specified intestinal infections

3.80

2.20

1.0

—

Asthma and allergy, excluding more controls

5.48

2.19

1.0

—

Coxarthrosis, primary

2.45

2.19

1.2

1.0

—

Other functional intestinal disorders

2.69

2.18

1.1

1.0

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

2.08

2.18

1.0

—

Desensitization to allergens

4.29

2.15

1.0

—

Budesonide

4.29

2.15

1.0

1.1

—

Migraine without aura and triptan purchases

3.00

2.14

1.1

1.0

—

Injuries to the knee and lower leg

1.79

2.14

1.1

1.0

—

Neurological diseases

2.01

2.12

1.0

—

All anxiety disorders

2.00

2.11

1.0

—

Other and unspecified tonsillitis

2.80

2.11

1.0

—

Coxibs

4.10

2.10

1.0

—

Viral and other specified intestinal infections

3.22

2.09

1.0

—

Fenamates

5.66

2.08

1.0

—

Acute tubulo-interstitial nephritis

2.16

2.07

1.1

1.0

—

Bacterial infection, other or unspecified

2.47

2.07

1.2

1.0

—

Other and unspecified disorders of skin and subcutaneous tissue

5.01

2.07

1.0

—

Rash and other nonspecific skin eruption

5.00

2.07

1.2

1.0

—

Hernia of abdominal wall, postoperative

5.00

2.07

1.0

—

Fracture of foot, except ankle

2.90

2.07

1.2

1.0

—

Other disorders of breast

3.50

2.05

1.0

1.1

—

Diseases of oral cavity, salivary glands and jaws

2.34

2.05

1.1

1.0

—

Diseases of pulp and periapical tissues and dental caries

2.14

2.04

1.1

1.0

—

Congenital malformations and deformations of the musculoskeletal system

3.98

2.02

1.0

—

Gonarthrosis, primary, with knee surgery

2.45

2.01

1.1

—

Propionic acid derivatives

3.91

2.01

1.0

—

Anti-inflammatory and antirheumatic products, non-steroids

3.91

2.01

1.0

—

Gout

4.89

2.00

1.2

1.1

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

2.60

1.99

1.0

—

Other headache syndromes

2.28

1.97

1.1

1.0

—

Ventral hernia

3.33

1.96

1.0

—

Postmenopausal bleeding

3.28

1.95

1.0

—

Spirochaetal infections, other/unspecified

4.55

1.94

1.0

—

Smoking dependency

4.55

1.94

1.0

—

Mental and behavioural disorders due to tobacco

4.55

1.94

1.0

—

Triptan medication for migraine, single purchase ok

1.89

1.94

1.0

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

1.89

1.94

1.0

—

ILD medications: azathioprine

4.55

1.94

1.0

—

Disorders of parathyroid gland

3.29

1.94

1.1

1.0

—

Dislocation, sprain and strain of joints and ligaments at neck level

3.75

1.93

1.2

1.0

—

Migraine without aura

2.73

1.93

1.1

1.0

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

2.13

1.91

1.0

—

Anxiety (asthma-related co-morbidities)

1.96

1.91

1.0

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

4.48

1.91

1.0

—

Other reaction to severe stress, and adjustment disorders

2.24

1.90

1.1

1.0

—

Artrosis, including avohilmo

2.05

1.89

1.1

1.0

—

Enthesopathies of lower limb, excluding foot

3.18

1.88

1.0

—

Primary coxarthrosis, bilateral

3.18

1.88

1.3

1.0

—

Diseases of middle ear and mastoid

2.02

1.87

1.0

—

Nonsuppurative otitis media

2.69

1.86

1.0

—

Open wound of head

2.41

1.86

1.1

1.0

—

Contraceptive management

2.28

1.84

1.0

—

Open wound of lower leg

3.53

1.83

1.2

1.1

—

Other bacterial intestinal infections

3.53

1.83

1.0

—

Arthrosis

2.26

1.83

1.0

—

Vitreous haemorrhage

4.17

1.82

1.2

1.0

—

Triptan medication for migraine, min. 3 purchases

1.88

1.81

1.1

1.0

—

Disorders of vitreous body

2.27

1.80

1.1

1.0

—

Tonsillectomy and adenotomy

2.01

1.79

1.0

—

Disorders of the thyroid gland

1.78

1.77

1.0

—

Allergic conjunctivitis

1.91

1.76

1.0

—

Heart failure and bmi 25plus

2.84

1.76

1.1

—

Artificial joint operation, meniscal resection

1.88

1.75

1.1

1.0

—

Disease of hard tissues of teeth, NOS

2.22

1.75

1.1

1.0

—

Glomerular diseases

3.33

1.74

1.3

1.0

—

Other viral diseases

2.32

1.74

1.0

—

Unspecified fall

2.23

1.74

1.0

—

Osteoporosis

2.97

1.74

1.0

—

1.92

1.73

1.1

1.0

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1.92

1.73

1.1

1.0

—

Other enthesopathies

2.67

1.72

1.0

—

Sequelae of injuries, of poisoning and of other consequences of external causes

2.92

1.72

1.1

1.0

—

Other diseases of anus and rectum

2.91

1.71

1.0

—

Collagenous colitis

3.85

1.71

1.0

1.1

—

Other psoriatic arthropathies

3.85

1.71

1.2

1.0

—

Psoriatic arthropathies, ICD10

3.85

1.71

1.2

1.0

—

Arthropathic psoriasis

3.85

1.71

1.2

1.0

—

Azathioprine

3.85

1.71

1.0

1.1

—

Iron deficiency anaemia secondary to blood loss (chronic)

3.85

1.71

1.2

1.1

—

Disorders of vitreous body and globe

2.22

1.71

1.1

1.0

—

Malignant neoplasm of skin

2.28

1.71

1.0

—

Fitting and adjustment of other devices

2.67

1.71

1.1

1.0

—

Injuries to the ankle and foot

1.86

1.70

1.1

1.0

—

Other diseases of hard tissues of teeth

2.19

1.70

1.1

1.0

—

Hypothyroidism and >3 levothyroxin purchases

2.83

1.70

1.0

1.1

—

Hypothyroidism, levothyroxine purchases

2.83

1.70

1.0

1.1

—

Benzodiazepine use

100

1.72

1.69

1.1

1.0

—

Senile cataract

2.21

1.68

1.2

1.0

—

Endocrine, nutritional and metabolic diseases

1.92

1.68

1.0

—

Disorders of lens

2.13

1.68

1.1

1.0

—

Dental caries

3.20

1.67

1.2

1.0

—

Insulin, combination of fast acting with intermediate-acting or long-acting

2.12

1.67

1.1

1.0

—

Peripheral artery disease

2.65

1.66

1.0

1.1

—

Other noninflammatory disorders of uterus, except cervix

3.37

1.66

1.2

1.0

—

Other predominantly sexually transmitted diseases, not elsewhere classified

2.80

1.65

1.0

—

Mycoses

2.80

1.65

1.0

—

Abnormal findings on diagnostic imaging of lung

2.46

1.64

1.0

1.1

—

Behavioural syndromes associated with physiological disturbances and physical factors

1.72

1.64

1.0

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

2.33

1.63

1.0

—

Dysplasia of cervi uteri

2.63

1.63

1.0

—

Any reimbursement code in KELA

2.09

1.63

1.0

—

Open wound of wrist and hand

2.24

1.62

1.1

—

Psoriatic and enteropathic arthropathies

3.57

1.61

1.2

1.1

—

Radiculopathy

3.57

1.61

1.4

1.1

—

Other and unspecified polyneuropathies, also in other diseases

3.57

1.61

1.0

1.1

—

Disorders of other endocrine glands

2.15

1.60

1.1

1.0

—

Missing teeth due to accident, extraction or parodontitis

2.08

1.60

1.1

1.0

—

Dental pulpitis, including avohilmo

1.71

1.59

1.0

—

Anaemias

2.86

1.59

1.1

—

Bacterial infection, other or unspecified

2.34

1.58

1.2

1.0

—

Other viral diseases, not elsewhere classified

2.99

1.57

1.0

—

Transport accidents

2.32

1.57

1.1

1.0

—

Sensorineural hearing loss

1.94

1.56

1.1

1.0

—

Benign neoplasms

1.74

1.55

1.0

—

Chronic kidney disease

2.94

1.54

1.2

1.0

—

Excessive attrition of teeth

1.88

1.54

1.1

1.0

—

Haemorrhage in early pregnancy

2.19

1.53

1.0

—

Psoriasis

2.43

1.53

1.3

1.0

—

Asthma-related pneumonia

2.42

1.53

1.0

—

Asthma-related pneumonia or sepsis

2.42

1.53

1.0

—

Asthma, hospital admissions 3, pneumonia

2.42

1.53

1.0

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2.10

1.53

1.1

1.0

—

Conductive and sensorineural hearing loss

1.88

1.52

1.1

1.0

—

Thyroiditis, ILD-related definition

3.34

1.52

1.0

—

Noninfectious colitis NAS

3.33

1.52

1.0

1.1

—

Polyneuropathies and other disorders of the peripheral nervous system

3.33

1.52

1.0

1.1

—

Diverticular disease of intestine

2.03

1.52

1.1

1.0

—

Meniscus derangement

2.25

1.51

1.1

1.0

—

Hypo-osmolality and hyponatraemia

3.32

1.51

1.2

1.0

—

Colonic or urogenital fistula

2.59

1.51

1.1

1.0

—

Type 1 diabetes

2.59

1.51

1.0

—

Fissure and fistula of anal and rectal regions

2.86

1.50

1.2

1.0

—

Zoster [herpes zoster]

2.86

1.50

1.2

1.0

—

Nonorganic sleeping disorders, excluding more controls

2.86

1.50

1.0

—

Heart failure and antihypertensive medication

3.02

1.50

1.2

1.0

—

Chronic apical periodontitis

1.64

1.50

1.0

—

Perineal laceration during delivery

2.51

1.50

1.0

—

Caries of dentine

3.24

1.48

1.2

1.0

—

Disorders of skin appendages

2.00

1.48

1.0

—

Lyme disease

2.43

1.47

1.0

—

Spirochaetal infections, other/unspecified

2.43

1.47

1.0

—

Other spirochaetal diseases

2.43

1.47

1.0

—

Other spirochaetal diseases

2.43

1.47

1.0

—

Disturbances of skin sensation

2.37

1.45

1.0

—

Injuries to the neck

2.50

1.45

1.1

1.0

—

Non-selective monoamine reuptake inhibitors

2.34

1.44

1.1

1.0

—

Coxarthrosis, primary, with hip surgery

2.34

1.44

1.2

1.0

—

Sleep apnoea

1.72

1.44

1.0

—

Disorders of continuity of bone

3.13

1.44

1.0

—

Paralytic ileus and intestinal obstruction

3.12

1.43

1.0

1.1

—

Unspecified haematuria

2.52

1.43

1.1

1.0

—

Substance use, excluding alcohol

2.73

1.43

1.0

—

Otitis externa

2.73

1.43

1.0

—

Symptoms and signs involving the nervous and musculoskeletal systems

1.92

1.43

1.0

—

Neoplasms

1.80

1.43

1.0

—

All chronic kidney diseases

2.14

1.43

1.2

1.0

—

Diabetic retinopathy, strict definition

3.15

1.43

1.0

1.1

—

Skin changes due to chronic exposure to nonionizing radiation

2.48

1.42

1.0

—

Episodal and paroxysmal disorders

1.65

1.42

1.0

—

Retention of urine

2.74

1.40

1.2

1.1

—

Excessive earwax

2.02

1.40

1.1

1.0

—

Procreative management

2.27

1.40

1.0

—

Sleep disorders (combined)

1.62

1.40

1.0

—

Leiomyoma of uterus

1.74

1.39

1.0

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1.66

1.39

1.0

—

Dental operations

2.00

1.39

1.1

1.0

—

Non-invasive ventilation

2.68

1.39

1.0

1.1

—

Zoster [herpes zoster]

2.08

1.39

1.1

1.0

—

Endometriosis

2.29

1.38

1.0

—

Carpal tunnel syndrome

1.90

1.37

1.2

1.0

—

Retained placenta and membranes, without haemorrhage

2.94

1.36

1.0

—

Abnormal involuntary movements

2.94

1.36

1.0

1.1

—

Gout, FINNGEN

2.93

1.35

1.2

1.1

—

2.38

1.35

1.0

—

Irregular menses

1.77

1.33

1.1

1.0

—

Childhood allergy (age < 16)

2.94

1.33

1.0

—

Exposure to other specified factors

1.72

1.32

1.1

1.0

—

Exposure to unspecified factor

102

1.62

1.32

1.1

1.0

—

Viral infections characterized by skin and mucous membrane lesions

2.04

1.32

1.1

1.0

—

Caries of enamel

1.64

1.31

1.0

—

Insulin medication

1.92

1.30

1.1

1.0

—

Nontoxic multinodular goitre

2.50

1.30

1.0

—

IBD patients in KELA-register

2.50

1.30

1.0

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

2.05

1.29

1.1

1.0

—

DVT of lower extremities and pulmonary embolism

2.08

1.29

1.2

1.0

—

Benign paroxysmal vertigo

2.35

1.29

1.0

—

Endometriosis of pelvic peritoneum

2.80

1.29

1.0

—

Spondylolisthesis/Spondylolysis

2.78

1.28

1.2

1.1

—

Peritonsillar abscess

2.78

1.28

1.0

—

Other antidepressants

1.66

1.28

1.0

—

Sleep disorders

1.62

1.27

1.0

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1.64

1.27

1.0

—

Arthropathies

1.75

1.26

1.0

—

Mood disorders, excluding more controls

1.65

1.25

1.0

—

Ectopic pregnancy

2.40

1.24

1.0

—

L04AA Selective immunosuppressants

2.40

1.24

1.3

1.0

—

Inflammatory bowel disease, strict (require KELA)

2.40

1.24

1.0

—

Haemorrhoids and perianal venous thrombosis

2.39

1.24

1.0

—

Insulin, intermediate and long-acting

1.98

1.23

1.0

—

Hernia of abdominal wall

2.04

1.21

1.0

1.1

—

5-aminosalicylic acid

2.63

1.21

1.0

1.1

—

Acetic acid derivatives and related substances

2.88

1.21

1.0

—

Diseases of arteries, arterioles and capillaries

1.93

1.20

1.0

1.1

—

Hypothyroidism, strict autoimmune

1.72

1.19

1.0

—

Infections with a predominantly sexual mode of transmission

1.89

1.19

1.0

—

Female infertility, cervical, vaginal, other or unspecified origin

2.17

1.19

1.0

—

Superficial injury of wrist and hand

2.31

1.18

1.0

—

Depression

1.57

1.18

1.1

1.0

—

Actinic keratosis

2.31

1.18

1.0

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

0.00

1.16

0.0

1.0

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1.58

1.16

1.1

1.0

—

Speech therapy

0.00

1.16

0.0

1.0

—

Leisure time condition

2.50

1.15

1.0

1.1

—

Tinnitus

2.50

1.15

1.2

1.0

—

Diabetes, insulin treatment (Kela reimbursement)

1.58

1.14

1.0

—

Hyperparathyroidism

2.47

1.13

1.2

1.1

—

Diabetes medication

1.55

1.13

1.0

—

Hypothyroidism, other/unspecified

1.59

1.12

1.0

—

Type 2 diabetes, wide definition

1.75

1.11

1.0

—

Sleep apnoea, including avohilmo

1.57

1.10

1.0

—

Hernia

1.60

1.09

1.0

—

Certain disorders involving the immune mechanism

2.38

1.09

1.0

—

Diagnoses used for exclusion with ILD

2.38

1.09

1.0

—

Other fall from one level to another

2.38

1.09

1.0

—

Nontoxic goitre/thyroid nodule

1.95

1.08

1.0

—

Subjective visual disturbances

2.19

1.08

1.0

—

Pure hypercholesterolaemia

1.80

1.07

1.1

1.0

—

Other maternal disorders predominantly related to pregnancy

1.61

1.07

1.1

1.0

—

Disorders of vestibular function (Vertigo)

1.93

1.06

1.0

—

Primary gonarthrosis, bilateral

2.03

1.05

1.0

1.1

—

Depression medications

2.20

1.05

1.0

1.1

—

Other predominantly sexually transmitted diseases, not elsewhere classified

2.12

1.05

1.0

—

Other diseases of pleura

2.12

1.05

1.3

1.0

—

Liquid cancers, helper endpoint

2.11

1.04

1.1

1.0

—

Gonarthrosis [arthrosis of knee](FG)

1.80

1.04

1.1

1.0

—

Valvular heart disease excluding rheumatic fever

2.11

1.03

1.1

1.0

—

Non-rheumatic valve diseases

2.10

1.03

1.1

1.0

—

Psoriasis vulgaris

2.27

1.03

1.2

1.0

—

Rotator cuff syndrome

1.94

1.02

1.0

—

Diseases of inner ear

1.83

1.02

1.0

—

Type 2 diabetes, definitions combined, including avohilmo

1.55

1.01

1.0

—

Pneumonia, organism unspecified

1.57

0.99

1.1

1.0

—

Caries of dentine, including avohilmo

1.64

0.99

1.1

1.0

—

Other neurological diseases

1.73

0.98

1.0

—

Outcome of delivery

0.00

0.98

0.0

1.0

—

In situ neoplasms

1.84

0.98

1.0

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1.83

0.98

1.2

1.0

—

D07AA Corticosteroids, weak (group I)

2.17

0.98

1.0

—

Complications of labour and delivery

1.58

0.98

1.0

—

Herpesviral [herpes simplex] infections

1.95

0.97

1.1

1.0

—

Inflammatory bowel disease

1.94

0.97

1.0

—

Benign neoplasm of ovary

0.00

0.96

0.0

1.0

—

Injuries to the wrist and hand

102

1.49

0.95

1.0

—

Hallux valgus (acquired)

1.94

0.95

1.0

—

Appendectomy

1.59

0.94

1.0

—

Atherosclerosis, excluding cerebral and coronary sclerosis

2.26

0.94

1.0

—

Voice disturbances

1.89

0.94

1.0

—

Disorders of adult personality and behaviour

1.89

0.94

1.0

—

Insulin, fast-acting

1.89

0.94

1.0

—

Ulcerative colitis

2.22

0.93

1.0

—

Intestinal stricture

2.22

0.93

1.0

—

Dental caries, including avohilmo

1.64

0.93

1.1

1.0

—

Metabolic disorders

1.53

0.92

1.1

1.0

—

Sulfasalazine

2.14

0.91

1.2

1.0

—

L04AX Other immunosuppressants

1.67

0.91

1.1

1.0

—

Nonorganic sleeping disorders

2.07

0.89

1.0

—

Other and unspecified disorders of vitreous body

1.92

0.89

1.1

1.0

—

Type 2 diabetes

1.48

0.88

1.0

—

Other benign neoplasms of skin

1.91

0.88

1.0

—

Sub-endpoint used in defining T1D endpoints

2.04

0.88

1.0

—

Psychiatric diseases

1.52

0.87

1.0

—

Other medical care

1.84

0.86

1.0

—

Reimbursement for rheumatic diseases

1.64

0.86

1.2

1.0

—

Postpartum care and examination

2.00

0.85

1.0

—

Fall on and from stairs and steps

1.94

0.84

1.2

1.0

—

Other arthritis (FG)

1.94

0.84

1.2

1.0

—

Acute appendicitis, no complications

1.62

0.83

1.1

1.0

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1.45

0.81

1.0

—

Alzheimer disease

0.00

0.81

0.0

1.1

—

Second line medication for Crohn's disease

1.60

0.81

1.1

1.0

—

Used for control exclusion in common control thyroid runs

1.50

0.80

1.0

—

Any mental disorder

1.45

0.80

1.0

—

Diabetic retinopathy

1.87

0.79

1.0

1.1

—

0.00

0.79

0.0

1.0

—

Benign lipomatous neoplasm

1.82

0.79

1.0

—

Alzheimer disease, including avohilmo

0.00

0.79

0.0

1.1

—

Injuries to the thorax

1.67

0.78

1.1

1.0

—

Benign leiomyoma with endometriosis

0.00

0.78

0.0

1.0

—

Irritable bowel syndrome

1.76

0.76

1.0

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1.46

0.76

1.0

—

Venous thromboembolism

1.69

0.75

1.2

1.0

—

Umbilical hernia

2.08

0.74

1.0

1.1

—

Superficial injury of head

2.08

0.74

1.2

1.0

—

Injuries to the elbow and forearm

1.52

0.74

1.1

1.0

—

Presence of other functional implants

1.64

0.73

1.1

1.0

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1.84

0.73

1.1

1.0

—

Diseases of liver

1.84

0.73

1.1

1.0

—

Covid-19 confirmed case

1.84

0.73

1.1

1.0

—

Other viral diseases

1.84

0.73

1.0

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

1.83

0.73

1.0

—

Generalized anxiety disorder

2.00

0.72

1.0

—

Type 1 diabetes, wide definition, subgroup 1

2.00

0.72

1.0

—

Insulin, fast-acting or short human

1.79

0.72

1.0

—

Fracture of shoulder and upper arm

1.79

0.72

1.0

—

Gonarthrosis

1.60

0.71

1.1

1.0

—

Disorders of lipoprotein metabolism and other lipidaemias

1.55

0.71

1.1

1.0

—

Unstable angina pectoris

1.97

0.71

1.0

1.1

—

Influenza and pneumonia

100

1.40

0.71

1.1

1.0

—

Abnormal findings on examination of blood, without diagnosis

1.74

0.70

1.1

1.0

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

1.92

0.70

1.0

—

Calculus of kidney and ureter

1.92

0.70

1.0

—

Fracture of rib(s), sternum and thoracic spine

1.92

0.70

1.0

—

Urolithiasis

1.92

0.70

1.0

—

Type 1 diabetes, wide definition

1.92

0.70

1.0

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

1.71

0.69

1.0

—

Viral warts

1.85

0.68

1.2

1.0

—

All dysplastic lesions of the cervix uteri, vagina or vulva

1.53

0.68

1.0

—

Symptoms and signs involving speech and voice

1.67

0.68

1.0

—

Other (not insulin) diabetes medications

1.41

0.68

1.1

1.0

—

Other strabismus

1.78

0.66

1.0

—

Diseases of pulp and periapical tissues, including avohilmo

1.39

0.65

1.0

—

Melanocytic naevi

1.59

0.65

1.0

—

Dermatophytosis

1.54

0.65

1.0

—

Female genital prolapse

1.77

0.64

1.0

—

Other menopausal disorders

1.76

0.63

1.0

—

Diabetic retinopathy, excluding more controls

1.75

0.63

1.0

1.1

—

Fracture of lower leg, including ankle

1.60

0.62

1.0

—

Suppurative and unspecified otitis media

1.65

0.62

1.0

—

Endometriosis ASRM stages 1,2

1.67

0.61

1.0

—

Other degenerative diseases of the nervous system

0.00

0.61

0.0

1.0

—

Obesity, other/unspecified

1.60

0.61

1.0

—

Alzheimer’s disease, strict definition

0.00

0.61

0.0

1.1

—

Rheumatoid arthritis

1.66

0.61

1.4

1.0

—

Disturbance of activity and attention

0.00

0.60

0.0

1.0

—

Twin gestation

0.00

0.60

0.0

1.0

—

Hyperkinetic disorders

0.00

0.60

0.0

1.0

—

Complications predominantly related to the puerperium

1.57

0.60

1.0

—

Malignant neoplasm of breast, HER-positive

1.56

0.60

1.0

—

Schizophrenia

0.00

0.60

0.0

1.0

—

Use of hypnotics and sedatives

1.35

0.58

1.0

—

Other symptoms and signs involving the nervous and musculoskeletal systems

1.51

0.58

1.0

—

Type 2 diabetes, strict (exclude DM1)

1.38

0.58

1.1

1.0

—

Type 2 diabetes, definitions combined

1.38

0.58

1.1

1.0

—

Malignant neoplasm of breast, ER-positive, including Hilmo

1.50

0.58

1.0

—

Mood [affective] disorders

101

1.35

0.58

1.0

—

Localized swelling, mass and lump of skin and subcutaneous tissue

1.71

0.57

1.0

—

Glaucoma suspect

1.71

0.57

1.0

—

Mood disorders

101

1.34

0.57

1.0

—

Diabetes mellitus

1.35

0.57

1.0

—

Hypertension, essential

1.39

0.55

1.1

1.0

—

Selective serotonin reuptake inhibitors

1.38

0.55

1.0

—

Other symptoms and signs involving cognitive functions and awareness

1.61

0.55

1.2

1.0

—

Gonarthrosis,primary

1.42

0.55

1.1

1.0

—

Other cataract

1.57

0.53

1.0

—

Maternal care for other known or suspected fetal problems

1.54

0.52

1.0

—

Gingivitis and periodontal diseases

1.34

0.52

1.1

1.0

—

Aplastic and other anaemias

1.51

0.52

1.3

1.0

—

Maternal care for other conditions predominantly related to pregnancy

1.51

0.52

1.0

—

Other disorders of eyelid

1.50

0.51

1.0

—

Supervision of normal pregnancy

1.60

0.50

1.0

—

Other abnormal products of conception

1.49

0.50

1.0

—

Exclusions for E4_PCOS_CONSORTIUM

1.34

0.49

1.0

—

Disorders of breast

1.40

0.48

1.0

—

Injuries to the hip and thigh

1.51

0.48

1.1

1.0

—

Transient ischemic attack

1.49

0.47

1.0

1.1

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1.49

0.47

1.0

—

Insomnia

1.32

0.47

1.0

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1.46

0.46

1.0

—

Biguanides

1.32

0.45

1.1

1.0

—

Benign neoplasm: Colon

1.39

0.44

1.1

1.0

—

Polyp of the female genital tract

1.69

0.44

1.0

—

Diabetes, varying definitions

1.29

0.43

1.1

1.0

—

Acute appendicitis

1.35

0.43

1.1

1.0

—

Specific personality disorders

1.61

0.43

1.0

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1.61

0.43

1.0

—

Appendicitis, broad definition

102

1.33

0.42

1.1

1.0

—

Other disorders of amniotic fluid and membranes

1.57

0.42

1.2

1.0

—

Glaucoma

1.40

0.42

1.0

—

Major coronary heart disease event

1.38

0.42

1.0

1.1

—

Later onset COPD

0.00

0.41

0.0

1.1

—

Malignant neoplasm of respiratory system and intrathoracic organs

0.00

0.41

0.0

1.0

—

Malignant neoplasm of bronchus and lung, including Hilmo

0.00

0.41

0.0

1.0

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

0.00

0.41

0.0

1.1

—

Diseases of appendix

102

1.33

0.41

1.1

1.0

—

Necrosis of pulp, including avohilmo

1.38

0.41

1.0

—

Alzheimer’s disease (Late onset)

0.00

0.41

0.0

1.1

—

Injuries to the shoulder and upper arm

1.34

0.41

1.0

—

Suicide or other Intentional self-harm

1.52

0.41

1.0

—

Ovarian dysfunction

0.00

0.41

0.0

1.0

—

Social phobias

0.00

0.41

0.0

1.0

—

Injuries to unspecified part of trunk, limb or body region

0.00

0.41

0.0

1.0

—

Acute and transient psychotic disorders

0.00

0.41

0.0

1.0

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

0.00

0.41

0.0

1.0

—

Strabismus

1.51

0.41

1.0

—

MS-disease / Multiple Sclerosis

0.00

0.41

0.0

1.0

—

Embedded teeth, including avohilmo

0.00

0.41

0.0

1.0

—

Burns and corrosions of external body surface, specified by site

0.00

0.41

0.0

1.0

—

Type 1 diabetes, strict definition, subgroup 1

0.00

0.41

0.0

1.0

—

Macular pucker

0.00

0.41

0.0

1.1

—

Burns and corrosions

0.00

0.41

0.0

1.0

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1.29

0.41

1.1

1.0

—

Hyperkinetic disorders, excluding more controls

0.00

0.41

0.0

1.0

—

0.00

0.41

0.0

1.1

—

Medicines for HER+ breast cancer

1.35

0.41

1.0

—

Demyelinating diseases of the central nervous system

0.00

0.40

0.0

1.0

—

Type 1 diabetes, strict definition

0.00

0.40

0.0

1.0

—

Use of memantine

0.00

0.40

0.0

1.1

—

Use of other anti-dementia drugs

0.00

0.40

0.0

1.1

—

Bitten or struck by other mammals

0.00

0.40

0.0

1.0

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

0.00

0.40

0.0

1.1

—

Phobic anxiety disorders

0.00

0.40

0.0

1.0

—

Type 1 diabetes, strict (exclude DM2)

0.00

0.40

0.0

1.0

—

Type 1 diabetes, definitions combined

0.00

0.40

0.0

1.0

—

Personal history of other diseases and conditions

0.00

0.39

0.0

1.0

—

Other heart diseases

1.37

0.39

1.0

—

Any event in cancer register

1.28

0.37

1.1

1.0

—

Other and unspecified anaemias

1.36

0.37

1.2

1.0

—

Other anaemias

1.36

0.37

1.2

1.0

—

Hard cardiovascular diseases

1.32

0.37

1.0

—

Benign neoplasm of colon, rectum, anus and anal canal

1.30

0.37

1.1

1.0

—

HSIL lesion of the cervix uteri, vagina or vulva

1.43

0.35

1.0

—

Endometriosis ASRM stages 3,4

1.43

0.35

1.0

—

L02BG Aromatase inhibitors

1.36

0.34

1.0

—

Long labour

1.32

0.33

1.0

—

Medical treatment for female infertility

1.30

0.33

1.0

—

Angina pectoris

1.37

0.32

1.0

1.1

—

Periodontitis

0.77

0.31

1.1

1.0

—

Ischemic heart diseases

1.30

0.31

1.0

1.1

—

Fracture of forearm

1.35

0.31

1.0

—

All dysplastic lesions of the cervix uteri

1.36

0.31

1.0

—

Chronic periodontitis, including avohilmo

0.77

0.31

1.1

1.0

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1.27

0.31

1.0

—

Pneumonias (Asthma/COPD co-morbidities)

1.23

0.30

1.1

1.0

—

Pregnancy, childbirth and the puerperium

1.26

0.30

1.1

1.0

—

Periapical abscess

1.25

0.29

1.0

—

Delivery, wide proxy

1.33

0.29

1.1

1.0

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1.26

0.28

1.0

—

Other obstetric conditions, not elsewhere classified

1.33

0.27

1.0

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

1.20

0.26

1.0

—

False labour

1.28

0.26

1.0

—

Malignant neoplasm of breast, HER2-negative

1.23

0.25

1.0

—

Hypertensive diseases (excluding secondary)

1.22

0.25

1.0

—

All pneumoniae

100

1.20

0.25

1.1

1.0

—

Persons encountering health services in circumstances related to reproduction

1.21

0.25

1.0

—

Percutaneous Coronary Intervention

1.27

0.23

1.0

1.1

—

Coronary revascularization (ANGIO or CABG)

1.27

0.23

1.0

1.1

—

Acute suppurative otitis media

1.33

0.23

1.0

—

HSIL lesion of the cervix uteri

1.25

0.22

1.0

—

Malignant neoplasm of prostate, including Hilmo

0.00

0.22

0.0

1.3

—

Malignant neoplasm of prostate

0.00

0.22

0.0

1.3

—

Hyperplasia of prostate

0.00

0.22

0.0

1.3

—

Supervision of high-risk pregnancy

1.20

0.22

1.0

—

Bleeding

1.24

0.22

1.1

1.0

—

Non-small cell lung cancer, including Hilmo

0.00

0.21

0.0

1.0

—

Acute nasopharyngitis (common cold)

0.00

0.21

0.0

1.0

—

Algoneurodystrophy

0.00

0.21

0.0

1.0

—

Other demyelinating diseases of the central nervous system

0.00

0.21

0.0

1.0

—

Delirium, not induced by alcohol and other psychoactive substances

0.00

0.21

0.0

1.1

—

Atopic conjunctivitis

0.00

0.21

0.0

1.0

—

Placenta praevia

0.00

0.21

0.0

1.0

—

Polyhydramnios

0.00

0.21

0.0

1.0

—

Family history of certain disabilities and chronic diseases leading to disablement

0.00

0.21

0.0

1.0

—

Dystonia

0.00

0.21

0.0

1.0

—

Maltreatment syndromes

0.00

0.21

0.0

1.0

—

Thyrotoxicosis with toxic multinodular goitre

0.00

0.21

0.0

1.1

—

Cerebral cysts

0.00

0.21

0.0

1.0

—

Polycystic ovarian syndrome

0.00

0.21

0.0

1.0

—

Scleritis and episcleritis

0.00

0.21

0.0

1.0

—

Nonspecific lymphadenitis

0.00

0.21

0.0

1.0

—

Other viral hepatitis

0.00

0.21

0.0

1.0

—

Injury of unspecified body region

0.00

0.21

0.0

1.0

—

Persistent delusional disorders

0.00

0.21

0.0

1.0

—

Divergent concomitant strabismus

0.00

0.21

0.0

1.0

—

Haemangioma, any site

0.00

0.21

0.0

1.0

—

Visual field defects

0.00

0.21

0.0

1.0

—

Persons encountering health services for specific procedures, not carried out

0.00

0.21

0.0

1.0

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

0.00

0.21

0.0

1.0

—

Sudden idiopathic hearing loss

0.00

0.21

0.0

1.0

—

Other mental disorders due to brain damage and dysfunction and to physical disease

0.00

0.21

0.0

1.1

—

Retinal vascular occlusion

0.00

0.21

0.0

1.1

—

Retinal vascular disorders

0.00

0.21

0.0

1.1

—

Myocardial infarction, with ST-elevation

0.00

0.21

0.0

1.1

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

0.00

0.21

0.0

1.0

—

Optic neuritis

0.00

0.21

0.0

1.0

—

Maternal care for known or suspected disproportion

0.00

0.21

0.0

1.0

—

Viral hepatitis

0.00

0.21

0.0

1.0

—

Conductive hearing loss, unspecified

0.00

0.21

0.0

1.0

—

Haemangioma and lymphangioma, any site

0.00

0.21

0.0

1.0

—

Subarachnoid haemorrhage

0.00

0.21

0.0

1.1

—

Preterm labour and delivery

1.16

0.21

1.0

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

0.00

0.21

0.0

1.0

—

Benign neoplasm: Cerebral meninges

0.00

0.21

0.0

1.1

—

Other specified and unspecified personality disorders

0.00

0.21

0.0

1.0

—

Infectious mononucleosis

0.00

0.21

0.0

1.0

—

Benign neoplasm of meninges

0.00

0.21

0.0

1.1

—

Injury of muscle and tendon at wrist and hand level

0.00

0.21

0.0

1.0

—

Type1 diabetes, definitions combined, early onset

0.00

0.21

0.0

1.0

—

Malignant neoplasm of bronchus and lung

0.00

0.20

0.0

1.0

—

Other congenital malformations of skin

0.00

0.20

0.0

1.0

—

Chalazion

0.00

0.20

0.0

1.0

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

0.00

0.20

0.0

1.0

—

Diseases of the digestive system

1.22

0.20

1.3

1.0

—

Major coronary heart disease event excluding revascularizations

1.18

0.19

1.0

1.1

—

Care involving use of rehabilitation procedures

1.24

0.19

1.1

1.0

—

Premature rupture of membranes

1.16

0.19

1.0

—

Rheumatoid arthritis, including avohilmo

1.15

0.19

1.3

1.0

—

Gestational [pregnancy-induced] hypertension

1.15

0.19

1.0

—

Statin medication

0.81

0.19

1.0

—

Maternal care for known or suspected abnormality of pelvic organs

1.16

0.18

1.0

—

Substance abuse, excluding more controls

1.13

0.17

1.0

—

STROKE

1.16

0.16

1.0

1.1

—

Mental and behavioural disorders due to psychoactive substance use

1.18

0.16

1.0

—

Congenital malformations, deformations and chromosomal abnormalities

1.19

0.16

1.0

—

Pregnancy with abortive outcome

1.16

0.16

1.0

—

Spontaneous abortion

1.19

0.16

1.0

—

Malignant neoplasm of breast

1.17

0.16

1.0

—

Cerebrovascular diseases

1.15

0.15

1.0

1.1

—

Ischaemic heart disease, wide definition

0.79

0.15

1.0

1.1

—

Emergency coronary revascularization (for ACS)

1.19

0.14

1.0

1.1

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

0.84

0.13

1.0

—

Malignant neoplasm, wide definition for exclusion

0.86

0.12

1.1

1.0

—

Gestational diabetes (for exclusion)

1.16

0.10

1.0

—

Other chronic obstructive pulmonary disease, including avohilmo

1.12

0.10

1.0

1.1

—

Obstructed labour due to malposition and malpresentation of fetus

1.11

0.10

1.0

—

Keratitis

1.09

0.09

1.0

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1.05

0.09

1.0

—

Labour and delivery complicated by fetal stress [distress]

1.12

0.09

1.0

—

Hypertension

1.11

0.08

1.1

1.0

—

Persons with potential health hazards related to communicable diseases

0.77

0.08

1.0

—

Substance abuse

1.06

0.08

1.0

—

Other retinal disorders

1.03

0.08

1.0

—

Disorders of sclera, cornea, iris and ciliary body

1.08

0.07

1.0

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

1.04

0.07

1.0

—

Malignant neoplasm of breast, including Hilmo

1.04

0.07

1.0

—

Hypertensive diseases

1.10

0.06

1.1

1.0

—

Single spontaneous delivery

1.13

0.06

1.0

—

Delivery

1.12

0.06

1.0

—

Solid cancers, helper endpoint

1.08

0.04

1.1

1.0

—

Malignant neoplasm

1.07

0.02

1.1

1.0

—

Congenital malformations, deformations and chromosomal abnormalities

1.07

0.01

1.0

—

Medical abortion

0.98

0.00

1.0

—

Haemorrhage, not elsewhere classified

0.00

0.0

1.0

—

Other and unspecified disease of Bartholin gland

0.00

0.0

1.0

—

Mental retardation, wide definition

0.00

0.0

1.0

—

Emphysema

0.00

0.0

1.0

—

Abnormal findings on examination of urine, without diagnosis

0.00

0.0

1.0

—

Other and unspecified injuries of ankle and foot

0.00

0.0

1.0

—

Lactose intolerance

0.00

0.0

1.0

—

Other specified disorders of kidney and ureter

0.00

0.0

1.0

—

Psychotic depression

0.00

0.0

1.0

—

Golimumab

0.00

0.0

1.0

—

Hypermetropia

0.00

0.0

1.0

—

Peripheral retinal degeneration

0.00

0.0

1.0

—

Normotensive glaucoma

0.00

0.0

1.1

—

Polypectomy (DHB20)

0.00

0.0

1.0

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

0.00

0.0

1.0

—

Viral conjunctivitis

0.00

0.0

1.0

—

Open wound of hip and thigh

0.00

0.0

1.0

—

Biomechanical lesions, not elsewhere classified

0.00

0.0

1.0

—

Malignant neoplasm of brain, including Hilmo

0.00

0.0

1.0

—

Other and unspecified mood [affective] disorders

0.00

0.0

1.0

—

Other pulmonary heart/vessel disease

0.00

0.0

1.0

—

Emotional disorders and disorders of social functioning with onset specific to childhood

0.00

0.0

1.0

—

Simple and mucopurulent chronic bronchitis

0.00

0.0

1.0

—

Personal history of certain other diseases

0.00

0.0

1.0

—

Perioral dermatitis

0.00

0.0

1.0

—

Burns and corrosions confined to eye and internal organs

0.00

0.0

1.0

—

Adenocarcinoma and papilloma adenocarcinoma of rectum

0.00

0.0

1.0

—

Other epidermal thickening

0.00

0.0

1.0

—

Use of interferon beta-1a

0.00

0.0

1.0

—

Malignant neoplasm of rectum, including Hilmo

0.00

0.0

1.0

—

Other disorders of Eustachian tube

0.00

0.0

1.0

—

Alzheimer disease, excluding more controls

0.00

0.0

1.0

—

Benign neoplasm of other and unspecified female genital organs

0.00

0.0

1.0

—

Other disorders starting during childhood or adolescence

0.00

0.0

1.0

—

Acute bronchiolitis

0.00

0.0

1.0

—

Brain meningioma, including Hilmo

0.00

0.0

1.0

—

Contact with heat and hot substances

0.00

-0.00

0.0

1.0

—

Exposure to other specified electric current

0.00

-0.00

0.0

1.0

—

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

0.00

-0.00

0.0

1.0

—

Helminthiases

0.00

-0.00

0.0

1.0

—

Other disorders starting during childhood or adolecense, excluding more controls

0.00

-0.00

0.0

1.0

—

Pneumothorax

0.00

-0.00

0.0

1.0

—

Other and unspecified injuries of wrist and hand

0.00

-0.00

0.0

1.0

—

6-mercaptopurine

0.00

-0.00

0.0

1.0

—

Viral haemorrhagic fevers, not elsewhere classified/unspecified

0.00

-0.00

0.0

1.0

—

Early complications of trauma

0.00

-0.00

0.0

1.0

—

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Traumatic subdural haemorrhage

0.00

-0.00

0.0

1.0

—

Arterial embolism and thrombosis

0.00

-0.00

0.0

1.0

—

Premature separation of placenta [abruptio placentae]

0.00

-0.00

0.0

1.0

—

Speech disturbances, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Carcinoma in situ of cervix uteri, endocervix

0.00

-0.00

0.0

1.0

—

Ill-defined and unknown causes of mortality

0.00

-0.00

0.0

1.0

—

Diabetes mellitus in pregnancy

0.97

-0.00

1.0

—

Somnolence, stupor and coma

0.00

-0.00

0.0

1.0

—

Diseases caused by chlamydiae

0.00

-0.00

0.0

1.0

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

0.00

-0.00

0.0

1.0

—

Congenital malformations of breast

0.00

-0.00

0.0

1.0

—

Spasmodic torticollis

0.00

-0.00

0.0

1.0

—

Other abnormal findings of blood chemistry

0.00

-0.00

0.0

1.0

—

Other ill-defined and unspecified causes of mortality

0.00

-0.00

0.0

1.0

—

Varicella [chickenpox]

0.00

-0.00

0.0

1.0

—

Mumps

0.00

-0.00

0.0

1.0

—

Disturbances of smell and taste

0.00

-0.00

0.0

1.0

—

Use of biperiden

0.00

-0.00

0.0

1.0

—

Use of galantamine

0.00

-0.00

0.0

1.1

—

Use of ropinirole

0.00

-0.00

0.0

1.0

—

L01XE Protein kinase inhibitors

0.00

-0.00

0.0

1.0

—

Certolizumab pegol

0.00

-0.00

0.0

1.0

—

Secondary and unspecified malignant neoplasm of lymph nodes

0.00

-0.00

0.0

1.0

—

Viral agents as the cause of diseases classified to other chapters

0.00

-0.00

0.0

1.0

—

Idiopathic pulmonary fibrosis

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of cervix uteri, including Hilmo

0.00

-0.00

0.0

1.0

—

Non-Hodgkin lymphoma, all, including Hilmo

0.00

-0.00

0.0

1.0

—

Major anomalies of jaw size

0.00

-0.00

0.0

1.0

—

Mental and behavioural disorders due to use of other stimulants, including caffeine

0.00

-0.00

0.0

1.0

—

0.00

-0.00

0.0

1.0

—

Complications of the puerperium, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Pathological resorption of teeth

0.00

-0.00

0.0

1.0

—

Agoraphobia

0.00

-0.00

0.0

1.0

—

malignant neoplasm of male genital organs

0.00

-0.00

0.0

1.3

—

Graves ophthalmopathy

0.00

-0.00

0.0

1.0

—

Mental and behavioural disorders due to cannabinoids

0.00

-0.00

0.0

1.0

—

Other assisted single delivery

0.00

-0.00

0.0

1.0

—

Other congenital malformations of skin

0.00

-0.00

0.0

1.0

—

Hydrocephalus

0.00

-0.00

0.0

1.1

—

Other conjunctival vascular disorders and cysts

0.00

-0.00

0.0

1.0

—

Cyst of kidney

0.00

-0.00

0.0

1.0

—

Disorders of speech understanding and production

0.00

-0.00

0.0

1.0

—

Unspecified mental disorder

0.88

-0.00

1.2

1.0

—

Mental and behavioural disorders due to opioids

0.00

-0.00

0.0

1.0

—

Graves ophthalmopathy, strict

0.00

-0.00

0.0

1.0

—

Other specified/unspecified inflammatory spondylopathies

0.00

-0.00

0.0

1.0

—

Other encephalitis

0.00

-0.00

0.0

1.0

—

Other lesions of median nerve

0.00

-0.00

0.0

1.0

—

Other and unspecified iridocyclitis

0.00

-0.00

0.0

1.0

—

Congenital malformations of the urinary system

0.00

-0.00

0.0

1.0

—

Thrombocytopenia, unspecified

0.00

-0.00

0.0

1.0

—

conjunctival degenerations and deposits

0.00

-0.00

0.0

1.0

—

Drug-induced neutropenia

0.00

-0.00

0.0

1.0

—

Aortic valve malfunction, age under 60 years

0.00

-0.00

0.0

1.0

—

Decubitus ulcer and pressure area

0.00

-0.00

0.0

1.0

—

Episcleritis

0.00

-0.00

0.0

1.0

—

Carcinoma in situ of skin of other and unspecified parts of face

0.00

-0.00

0.0

1.2

—

Benign neoplasm: Skin of ear and external auricular canal

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of head and neck

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Kidney

0.00

-0.00

0.0

1.0

—

Cirrhosis of liver, NAS

0.00

-0.00

0.0

1.0

—

Other and unspecified diseases of blood and blood-forming organs

0.00

-0.00

0.0

1.0

—

Other acute skin changes due to ultraviolet radiation

0.00

-0.00

0.0

1.0

—

Hirsutism in women

0.00

-0.00

0.0

1.0

—

Ulcerative ileocolitis

0.00

-0.00

0.0

1.0

—

Separation of retinal layers (serosa)

0.00

-0.00

0.0

1.0

—

Other diseases of blood and blood-forming organs

0.00

-0.00

0.0

1.0

—

Fracture of neck

0.00

-0.00

0.0

1.0

—

Other vitreous opacities

0.00

-0.00

0.0

1.0

—

Toxic effect of ethanol

0.00

-0.00

0.0

1.0

—

Dislocation, sprain and strain of joints and ligaments of head

0.00

-0.00

0.0

1.0

—

Non-follicular lymphoma

0.00

-0.00

0.0

1.0

—

Haemolytic anaemias

0.00

-0.00

0.0

1.0

—

Congenital malformations of uterus and cervix

0.00

-0.00

0.0

1.0

—

Secondary right heart disease

0.00

-0.00

0.0

1.0

—

Chronic viral hepatitis

0.00

-0.00

0.0

1.0

—

Cysts of oral region, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Invasive ventilation

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Liver/bile ducts

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

0.00

-0.00

0.0

1.0

—

Mental retardation

0.00

-0.00

0.0

1.0

—

!Aliquae complicationes praecoces traumatis

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of ovary

0.00

-0.00

0.0

1.0

—

Congenital malformations of breast

0.00

-0.00

0.0

1.0

—

Tuberculosis, IBD comorbidity

0.00

-0.00

0.0

1.0

—

Non-small cell lung cancer

0.00

-0.00

0.0

1.0

—

Multiple myeloma and malignant plasma cell neoplasms

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Skin, unspecified

0.00

-0.00

0.0

1.0

—

Unknown and unspecified causes of morbidity

0.00

-0.00

0.0

1.0

—

Carcinoma in situ of skin

0.00

-0.00

0.0

1.1

—

Exposure to other and unspecified animate mechanical forces

0.00

-0.00

0.0

1.0

—

Hyperhidrosis

0.00

-0.00

0.0

1.0

—

Emotional disorders starting during childhood or adolescence

0.00

-0.00

0.0

1.0

—

Tuberculosis, wide

0.00

-0.00

0.0

1.0

—

Contact with and exposure to communicable diseases

0.87

-0.00

1.0

—

Disorders of choroid and retina

0.93

-0.00

1.0

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

0.93

-0.00

1.0

—

Mental retardation, excluding more controls

0.00

-0.00

0.0

1.0

—

Additional codes for the location of defect, injury or illness

0.00

-0.00

0.0

1.0

—

Alzheimer’s disease (Atypical or mixed)

0.00

-0.00

0.0

1.2

—

Benign neoplasm: Liver

0.00

-0.00

0.0

1.0

—

Other and unspecified follicular disorders

0.00

-0.00

0.0

1.0

—

Other diseases caused by chlamydiae

0.00

-0.00

0.0

1.0

—

Specific development disorders of speech and language

0.00

-0.00

0.0

1.0

—

Vascular dementia

0.00

-0.00

0.0

1.2

—

Benign neoplasm: Pancreas

0.00

-0.00

0.0

1.0

—

Alzheimer’s disease (Early onset)

0.00

-0.00

0.0

1.0

—

Other obstructive and reflux uropathy

0.00

-0.00

0.0

1.0

—

Other disorders of pigmentation

0.00

-0.00

0.0

1.0

—

Lesion of radial nerve

0.00

-0.00

0.0

1.0

—

Other specified and unspecified disorders of eye and adnexa

0.00

-0.00

0.0

1.0

—

Brain meningioma

0.00

-0.00

0.0

1.0

—

Sequelae of other external causes

0.00

-0.00

0.0

1.0

—

Hypertrichosis

0.00

-0.00

0.0

1.0

—

Hemiplegia

0.00

-0.00

0.0

1.0

—

Tobacco use

0.00

-0.00

0.0

1.0

—

Astigmatism

0.00

-0.00

0.0

1.0

—

Injuries involving multiple body regions

0.00

-0.00

0.0

1.0

—

Fibrosis and cirrhosis of liver

0.00

-0.00

0.0

1.0

—

Impetigo

0.00

-0.00

0.0

1.0

—

Encephalitis

0.00

-0.00

0.0

1.0

—

Bullous disorders

0.00

-0.00

0.0

1.0

—

Use of rivastigmine

0.00

-0.00

0.0

1.1

—

Malignant neoplasm of rectum

0.00

-0.00

0.0

1.0

—

Chronic hepatitis, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Abnormal blood-pressure reading, without diagnosis

0.00

-0.00

0.0

1.0

—

Other and unspecified vascular occlusions

0.00

-0.00

0.0

1.1

—

Other specified and unspecified retinal disorders

0.00

-0.00

0.0

1.0

—

Lung cancer and mesothelioma

0.00

-0.00

0.0

1.0

—

Granulomatous disorders of skin and subcutaneous tissue

0.00

-0.00

0.0

1.0

—

Hereditary corneal dystrophies

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Conjunctiva

0.00

-0.00

0.0

1.0

—

Other congenital malformations of the digestive system

0.00

-0.00

0.0

1.0

—

Pregnancy hypertension

0.97

-0.00

1.0

—

Pre-eclampsia or poor fetal growth

0.96

-0.00

1.0

—

Other specified/unspecified hearing loss

0.00

-0.00

0.0

1.0

—

Benign neoplasm of urinary organs

0.00

-0.00

0.0

1.0

—

Other and unspecified acute skin changes due to ultraviolet radiation

0.00

-0.00

0.0

1.0

—

Cyst of Bartholin Gland

0.00

-0.00

0.0

1.0

—

Other/unspecified enthesopathies of lower limb, excluding foot

0.00

-0.00

0.0

1.0

—

Procedures for purposes other than remedying health state

0.00

-0.00

0.0

1.0

—

Secondary uncertain malignant neoplasm

0.00

-0.00

0.0

1.0

—

Chronic Coagulation defects

0.00

-0.00

0.0

1.0

—

Palmar fascial fibromatosis [Dupuytren]

0.00

-0.00

0.0

1.0

—

Keratoconus

0.00

-0.00

0.0

1.0

—

Right hemicolectomy

0.00

-0.00

0.0

1.0

—

Need for other prophylactic measures

0.00

-0.00

0.0

1.0

—

Osteonecrosis

0.00

-0.00

0.0

1.0

—

0.00

-0.00

0.0

1.0

—

Postprocedural musculoskeletal disorders, not elsewhere classified

0.00

-0.00

0.0

1.1

—

Lactose intolerance, other/unspecified

0.00

-0.00

0.0

1.0

—

Sacrococcygeal disorders, not elsewhere classified

0.00

-0.00

0.0

1.0

—

Other specified/unspecified soft tissue disorders

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

0.00

-0.00

0.0

1.0

—

Other renal tubulo-interstitial diseases

0.00

-0.00

0.0

1.0

—

Chronic nephritic syndrome

0.00

-0.00

0.0

1.0

—

Other/unspecified disorders of vestibular function

0.00

-0.00

0.0

1.0

—

Abscess of Bartholin gland

0.00

-0.00

0.0

1.0

—

Pedestrian injured in transport accident

0.00

-0.00

0.0

1.0

—

Viral conjunctivitis

0.00

-0.00

0.0

1.0

—

Other and unspecified glaucoma

0.00

-0.00

0.0

1.2

—

Car occupant injured in noncollision transport accident

0.00

-0.00

0.0

1.0

—

Chronic periodontitis, complicated

0.93

-0.00

1.0

—

Struck by thrown, projected or falling objec

0.00

-0.00

0.0

1.0

—

Other maltreatment syndromes

0.00

-0.00

0.0

1.0

—

Melanocytic naevi of lower limb, including hip

0.00

-0.00

0.0

1.0

—

Labour and delivery complicated by umbilical cord complications

0.00

-0.00

0.0

1.0

—

Other inflammation of vagina/vulva

0.00

-0.00

0.0

1.0

—

Macular hole

0.00

-0.00

0.0

1.2

—

Tubulo-interstitial nephritis, not specified as acute or chronic

0.00

-0.00

0.0

1.0

—

Alcoholic liver disease

0.00

-0.00

0.0

1.0

—

Diseases caused by chlamydiae

0.00

-0.00

0.0

1.0

—

L01XX Other antineoplastic agents

0.00

-0.00

0.0

1.0

—

Other diseases caused by chlamydiae

0.00

-0.00

0.0

1.0

—

Congenital malformations of the urinary system

0.00

-0.00

0.0

1.0

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Ampicillin IgE Ab [Units/volume] in Serum

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS